Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany
- Markus Resch1,
- Katrin Kurz2,
- Wulf Schneider-Brachert3,
- Kathrin Tintelnot4,
- Christoph Birner1,
- Thomas Schichtl1,
- Matthias Lubnow1,
- Christina Hart5,
- Clemens Jilek1,
- Simone Bertz2,
- Michael Hilker6,
- Günter A J Riegger1,
- Andreas Luchner1,
- Thomas Müller1
- 1Regensburg University Medical Center, Department of Internal Medicine II, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
- 2Regensburg University Medical Center, Department of Pathology, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
- 3Regensburg University Medical Center, Department of Microbiology, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
- 4Robert Koch-Institut, Nordufer 20, Berlin, 13353, Germany
- 5Regensburg University Medical Center, Department of Internal Medicine I, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
- 6Regensburg University Medical Center, Department of Cardiac and Thoracic Surgery, Franz-Josef-Strauss-Allee 11, Regensburg, 93053, Germany
- Markus Resch, Markus.Resch{at}klinik.uni-regensburg.de
- Published 28 June 2009
Summary
In fulminant blastomycosis with multiorgan failure, the earliest diagnosis possible is crucial for successful treatment. If severe acute respiratory distress syndrome (ARDS) develops, miniaturised veno-venous extracorporeal membrane oxygenation (ECMO) might provide a unique and efficacious possibility to prolong the time frame for diagnosis and the beginning of treatment. This is the first report on a case of fatal blastomycosis in Germany. It reminds us to add exotic infections to the differential diagnosis in patients with refractory pneumonia in the era of worldwide tourism.
Footnotes
-
Markus Resch and Kratin Kurz contributed equally to this case report
-
Competing interests: none.
-
Patient consent: Patient/guardian consent was obtained for publication








